Felipe Santa Rosa Roitberg (Felipe Roitberg)
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Khalid El Bairi, Dario Trapani, Sara Jamil Nidhamalddin, Shah Zeb Khan, Arman Reza Chowdhury, Csongor György Lengyel, Sadaqat Hussain, Baker Shalal Habeeb, Angelica Petrillo, Nabil Elhadi Omar, Sara Cecilia Altuna, Fahmi Usman Seid, Essam Elfaham, Andreas Seeber, Felipe Santa Rosa Roitberg, Alan Burguete-Torres, Safa El Kefi, Nazik Hammad, Miriam Mutebi, Ouissam Al Jarroudi, Nadia El Kadmiri, Curigliano Giuseppe, Said Afqir
- Manju Sengar, Adam M Fundytus, Wilma M Hopman, Conjeevaram S Pramesh, Venkatraman Radhakrishnan, Prasanth Ganesan, Aju Mathew, Dorothy Chilambe Lombe, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
- Avram E Denburg, Adam M Fundytus, Muhammad Saghir Khan, Scott C Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Chilambe Lombe, Wilma M Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
- Archita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, Christopher M Booth, Scott R Berry, Fidel Rubagumya, Felipe Santa Rosa Roitberg, Manju Sengar, Nazik Hammad
- Murallitharan Munisamy, Kingsley Ndoh, Ahmed Abdelbadee, Isthar Espejo, Florence Manjuh, Alexandra Tamas, Omolola Salako, Felipe Santa Rosa Roitberg
- Pedro Nazareth Aguiar, Carmelia Maria Noia Barreto, Felipe Santa Rosa Roitberg, Gilberto de Lima Lopes, Auro Del GiglioPotential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study. Sao Paulo medical journal = Revista paulista de medicina 137 (6) (2020)